InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by STANISLAS VEILLET, Chairman & CEO. Officer active across 1 company, notably BIOPHYTIS. In total, 5 disclosures have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €1.1m. Activity tracked since 7 June 2021. The latest transaction was disclosed on 5 March 2024 (Souscription). Regulator: AMF. The full history is free.
Declarations5 total
2,955,701 shares@ €0.0613.9% of flowOption d'achatEuronext Growth Paris2024DD953457
313,417 shares0Option d'achatEuronext Growth Paris2024DD953438
500,000 shares@ €0.99839.1% of flowActionEuronext Growth Paris2024DD953409
8,443,190 shares@ €0.00946.2% of flowActionEuronext Growth Paris2024DD953337
Ideal exit: 18 Aug 2024 (T+270)
569,271 shares@ €0.91440.8% of flowActionEuronext Growth Paris2021DD759762
5 of 5 declarations
About STANISLAS VEILLET
Stanislas Veillet is the Chairman & Chief Executive Officer of Biophytis, an innovative company in the biotechnology field. He leads the company's research and development efforts, focused on creating treatments for age-related diseases. With deep expertise in the sector, he plays a key role in the strategy and vision of Biophytis.
